{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:46:52Z","timestamp":1791690412352,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122873","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:00:13Z","timestamp":1791039613000},"page":"122873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid biopsy for early detection and biomarker applications in gynecological cancers: current status and future directions"],"prefix":"10.1016","volume":"594","author":[{"given":"Xia","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0005","article-title":"The global burden and associated factors of ovarian cancer in 1990\u20132019: findings from the Global Burden of Disease Study 2019","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Public Health [Internet]."},{"issue":"10","key":"10.1016\/j.cca.2026.122873_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.46234\/ccdcw2024.040","article-title":"Incidence and Mortality of Cancers in Female Genital Organs \u2014 China, 2022","volume":"6","author":"Sun","year":"2024","journal-title":"China CDC Wkly [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0015","article-title":"An umbrella review of socioeconomic status and cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun. [Internet]."},{"issue":"9","key":"10.1016\/j.cca.2026.122873_bb0020","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and Genomic Analysis of TP53 -Mutated Endometrial Carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin. Cancer Res. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0025","article-title":"Homologous recombination proficiency in ovarian and breast cancer patients","volume":"21","author":"Creeden","year":"2021","journal-title":"BMC Cancer [Internet]."},{"issue":"9","key":"10.1016\/j.cca.2026.122873_bb0030","article-title":"The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study","volume":"17","author":"Ryan","year":"2020","journal-title":"PLOS Med. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0035","article-title":"Socioeconomic Burden of Ovarian Cancer in 11 Countries","volume":"11","author":"Hutchinson","year":"2025","journal-title":"JCO Glob Oncol. [Internet]."},{"issue":"4","key":"10.1016\/j.cca.2026.122873_bb0040","article-title":"Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007\u20132014","volume":"31","author":"Yue","year":"2020","journal-title":"J. Gynecol. Oncol. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage","volume":"111","author":"Peres","year":"2018","journal-title":"JNCI J. Natl. Cancer Inst. [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0050","article-title":"Correction: Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice","volume":"44","author":"Martinelli","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res. [Internet]"},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.ogx.0000534156.01931.80","article-title":"Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement","volume":"73","year":"2018","journal-title":"Obstet & Gynecol Surv. [Internet]"},{"issue":"21","key":"10.1016\/j.cca.2026.122873_bb0060","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.3390\/diagnostics13213331","article-title":"Current and Emerging Strategies for Tubo-Ovarian Cancer Diagnostics","volume":"13","author":"Brincat","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0065","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0070","article-title":"Ovarian cancer detection by DNA methylation in cervical scrapings","volume":"11","author":"Wu","year":"2019","journal-title":"Clin. Epigenetics [Internet]"},{"issue":"11","key":"10.1016\/j.cca.2026.122873_bb0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/hvab168","article-title":"Liquid Biopsy: Blood-Based Analyses of ctDNA and CTCs","volume":"67","author":"Pantel","year":"2021","journal-title":"Clin. Chem. [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cpt.3416","article-title":"Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis","volume":"117","author":"Lockwood","year":"2024","journal-title":"Clin. Pharmacol. Ther. [Internet]"},{"issue":"8","key":"10.1016\/j.cca.2026.122873_bb0085","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jmoldx.2020.05.006","article-title":"Assessment of Pre-Analytical Sample Handling Conditions for Comprehensive Liquid Biopsy Analysis","volume":"22","author":"Gerber","year":"2020","journal-title":"J. Mol. Diagnostics [Internet]"},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0090","doi-asserted-by":"crossref","first-page":"112617","DOI":"10.1016\/j.isci.2025.112617","article-title":"Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detection","volume":"28","author":"Wang","year":"2025","journal-title":"iScience [Internet]"},{"key":"10.1016\/j.cca.2026.122873_bb0095","first-page":"15","article-title":"Clinical utility of various liquid biopsy samples for the early detection of ovarian cancer: a comprehensive review","author":"Feng","year":"2025","journal-title":"Front. Oncol. [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jmoldx.2023.09.004","article-title":"Recommendations for Cell-Free DNA Assay Validations","volume":"25","author":"Lockwood","year":"2023","journal-title":"J. Mol. Diagnostics [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0105","article-title":"Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature","volume":"13(4):838","author":"Guo","year":"2021","journal-title":"Cancers (Basel) [Internet]."},{"issue":"10","key":"10.1016\/j.cca.2026.122873_bb0110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.cca.2026.122873_bb0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.122873_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2026.122873_bb0125","article-title":"Liquid Biopsy, ctDNA Diagnosis through NGS","volume":"11(9):890","author":"Lin","year":"2021","journal-title":"Life [Internet]"},{"key":"10.1016\/j.cca.2026.122873_bb0130","article-title":"Next-generation sequencing methodologies to detect low-frequency mutations: \u201cCatch me if you can\u201d","volume":"792","author":"Menon","year":"2023","journal-title":"Mutat Res. - Rev. Mutat. Res. [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0135","article-title":"Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA","volume":"13","author":"Gale","year":"2018","journal-title":"PLoS One [Internet]"},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41379-018-0158-8","article-title":"Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients","volume":"32","author":"Bolivar","year":"2019","journal-title":"Mod. Pathol. [Internet]."},{"issue":"21","key":"10.1016\/j.cca.2026.122873_bb0145","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1073\/pnas.1601311113","article-title":"Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues","volume":"113","author":"Krimmel","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.cca.2026.122873_bb0150","article-title":"Early detection, clinicopathological subtyping, and prognosis prediction for endometrial cancer patients using fragmentomics liquid biopsy assay","volume":"10","author":"Rao","year":"2025","journal-title":"ESMO Open [Internet]"},{"issue":"7","key":"10.1016\/j.cca.2026.122873_bb0155","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.34981","article-title":"Fragmentomics features of ovarian cancer","volume":"155","author":"Chao","year":"2024","journal-title":"Int. J. Cancer [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0160","article-title":"Refined characterization of circulating tumor DNA through biological feature integration","volume":"12","author":"Markus","year":"2022","journal-title":"Sci. Rep. [Internet]."},{"issue":"10","key":"10.1016\/j.cca.2026.122873_bb0165","article-title":"Cell-free DNA end characteristics enable accurate and sensitive cancer diagnosis","volume":"4","author":"Ju","year":"2024","journal-title":"Cell Reports Methods [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0170","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jmoldx.2018.07.005","article-title":"Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients","volume":"20","author":"Risberg","year":"2018","journal-title":"J. Mol. Diagnostics [Internet]."},{"issue":"13","key":"10.1016\/j.cca.2026.122873_bb0175","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1158\/1078-0432.CCR-24-3335","article-title":"Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients","volume":"31","author":"Magee","year":"2025","journal-title":"Clin. Cancer Res. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0180","article-title":"Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib","volume":"7(12):1772","author":"Kwan","year":"2021","journal-title":"JAMA Oncol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0185","first-page":"12","article-title":"The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples","author":"Peng","year":"2024","journal-title":"Front. Cell. Dev. Biol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0190","doi-asserted-by":"crossref","first-page":"104237","DOI":"10.1016\/j.ebiom.2022.104237","article-title":"Circulating tumor cell isolation for cancer diagnosis and prognosis","volume":"83","author":"Deng","year":"2022","journal-title":"eBioMedicine [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0195","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal Transduct Target Ther. [Internet]."},{"issue":"7","key":"10.1016\/j.cca.2026.122873_bb0200","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer \u2013 Establishment of a multi-marker gene panel","volume":"10","author":"Blassl","year":"2016","journal-title":"Mol. Oncol. [Internet]."},{"issue":"24","key":"10.1016\/j.cca.2026.122873_bb0205","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3390\/cancers14246030","article-title":"The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination","volume":"14","author":"Szczerba","year":"2022","journal-title":"Cancers (Basel) [Internet]"},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0215","article-title":"Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS One [Internet]"},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0220","article-title":"Circulating tumour cells: The Good, the Bad and the Ugly","volume":"1878","author":"Bates","year":"2023","journal-title":"Biochim. Biophys. Acta - Rev. Cancer [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0225","doi-asserted-by":"crossref","first-page":"120771","DOI":"10.1016\/j.cca.2025.120771","article-title":"Exosomal microRNA biomarkers in ovarian cancer detection: systematic review and meta-analysis","volume":"584","author":"Huang","year":"2026","journal-title":"Clin. Chim. Acta [Internet]."},{"issue":"15","key":"10.1016\/j.cca.2026.122873_bb0230","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1158\/1078-0432.CCR-21-0267","article-title":"OCaMIR\u2014A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study","volume":"27","author":"Kandimalla","year":"2021","journal-title":"Clin. Cancer Res. [Internet]."},{"issue":"8","key":"10.1016\/j.cca.2026.122873_bb0235","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41416-022-01925-0","article-title":"A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis","volume":"127","author":"Gahlawat","year":"2022","journal-title":"Br J. Cancer [Internet]."},{"issue":"10)","key":"10.1016\/j.cca.2026.122873_bb0240","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/biomedicines9101433","article-title":"Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer","volume":"9","author":"Shiao","year":"2021","journal-title":"Biomedicines [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0245","first-page":"9","article-title":"Review on Strategies and Technologies for Exosome Isolation and Purification","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol. [Internet]."},{"issue":"18","key":"10.1016\/j.cca.2026.122873_bb0250","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/ijms21186466","article-title":"A review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00795-022-00338-5","article-title":"Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy","volume":"56","author":"Someya","year":"2022","journal-title":"Med. Mol. Morphol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0260","first-page":"9","article-title":"Predict ovarian cancer by pairing serum miRNAs: Construct of single sample classifiers","author":"Hong","year":"2022","journal-title":"Front. Med. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0265","article-title":"Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review","volume":"15","author":"Terp","year":"2023","journal-title":"Clin. Epigenetics [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2013.04.048","article-title":"A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA","volume":"130","author":"Zhang","year":"2013","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0275","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/clinchem\/hvac020","article-title":"Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma","volume":"68","author":"Beinse","year":"2022","journal-title":"Clin. Chem. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0280","article-title":"Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application","volume":"43","author":"Casas-Arozamena","year":"2024","journal-title":"J. Exp. & Clin. Cancer Res. [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0285","article-title":"Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer","volume":"12","author":"Bahado-Singh","year":"2022","journal-title":"Sci. Rep. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1078-0432.CCR-16-0863","article-title":"Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings","volume":"23","author":"Huang","year":"2017","journal-title":"Clin. Cancer Res. [Internet]."},{"issue":"20","key":"10.1016\/j.cca.2026.122873_bb0295","article-title":"Performance of Liquid Biopsy-Based Multi-Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE-I)","volume":"12","author":"Feng","year":"2025","journal-title":"Adv. Sci. [Internet]."},{"issue":"9","key":"10.1016\/j.cca.2026.122873_bb0300","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol. [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/03008916221133136","article-title":"Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options","volume":"109","author":"Shao","year":"2022","journal-title":"Tumori J. [Internet]."},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ccell.2022.01.012","article-title":"New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening","volume":"40","author":"Hackshaw","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cca.2026.122873_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2025.10.003","article-title":"Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samples","volume":"203","author":"Manning","year":"2025","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0320","article-title":"Circulating tumor DNA in the diagnosis of ovarian cancer: a systematic review","volume":"36","author":"Taliento","year":"2026","journal-title":"Int. J. Gynecol. Cancer [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5603\/gpl.103762","article-title":"Integration of ultrasonography and circulating tumor DNA analysis enhances early detection of asymptomatic ovarian cancer","volume":"97","author":"Jiapaer","year":"2026","journal-title":"Ginekol Pol. [Internet]."},{"issue":"22","key":"10.1016\/j.cca.2026.122873_bb0330","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.3390\/cancers13225731","article-title":"Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers (Basel) [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0335","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2023.04.014","article-title":"Detection of endometrial cancer using tampon-based collection and methylated DNA markers","volume":"174","author":"Bakkum-Gamez","year":"2023","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"5","key":"10.1016\/j.cca.2026.122873_bb0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/dc.70081","article-title":"DNA Methylation of Combined Gene Markers in Cytological Specimens for Endometrial Cancer Screening","volume":"54","author":"Hu","year":"2026","journal-title":"Diagn Cytopathol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0345","article-title":"Liquid biopsy biomarkers in cervical cancer: A systematic review and meta-analysis","volume":"10","author":"Njangiru","year":"2025","journal-title":"J. Liq. Biopsy [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0350","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1940-6207.CAPR-16-0138","article-title":"Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes","volume":"9","author":"Guerrero-Preston","year":"2016","journal-title":"Cancer Prev. Res. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0355","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2022.07.028","article-title":"Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer","volume":"167","author":"Sivars","year":"2022","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0360","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/cancers18030438","article-title":"Liquid Biopsy Analysis of the EV-Associated Micro-RNA Signature in Vulvar Carcinoma May Benefit Disease Diagnosis and Prognosis","volume":"18","author":"Borchardt","year":"2026","journal-title":"Cancers (Basel) [Internet]."},{"issue":"24","key":"10.1016\/j.cca.2026.122873_bb0365","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.3390\/cancers13246339","article-title":"New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers","volume":"13","author":"Holcakova","year":"2021","journal-title":"Cancers (Basel) [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0370","article-title":"Applying low coverage whole genome sequencing to detect malignant ovarian mass","volume":"19","author":"Chen","year":"2021","journal-title":"J. Transl. Med. [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0375","article-title":"Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study","volume":"13","author":"Parkinson","year":"2016","journal-title":"PLOS Med. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0380","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2019.11.012","article-title":"Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer","volume":"125","author":"Rusan","year":"2020","journal-title":"Eur. J. Cancer [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0385","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/genes15060750","article-title":"Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients","volume":"15","author":"Senturk Kirmizitas","year":"2024","journal-title":"Genes. (Basel) [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0390","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/0008-5472.CAN-23-1429","article-title":"Serial Circulating Tumor DNA Analysis with a Tumor-Na\u00efve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer","volume":"84","author":"Heo","year":"2023","journal-title":"Cancer Res. [Internet]."},{"issue":"11","key":"10.1016\/j.cca.2026.122873_bb0395","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/ijgc-2024-005581","article-title":"Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas","volume":"34","author":"Kfoury","year":"2024","journal-title":"Int. J. Gynecol. Cancer [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2021.03.006","article-title":"Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival","volume":"149","author":"Jakobsen","year":"2021","journal-title":"Eur. J. Cancer [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2025.11.005","article-title":"Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?","volume":"204","author":"Toboni","year":"2026","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0410","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/ijgc-2024-005313","article-title":"Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis","volume":"34","author":"Taliento","year":"2024","journal-title":"Int. J. Gynecol. Cancer [Internet]."},{"issue":"4","key":"10.1016\/j.cca.2026.122873_bb0415","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.33362","article-title":"Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer","volume":"148","author":"Tian","year":"2020","journal-title":"Int. J. Cancer [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0420","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol [Internet]"},{"issue":"18","key":"10.1016\/j.cca.2026.122873_bb0425","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3390\/cancers16183117","article-title":"The Role of Circulating Tumor DNA in Ovarian Cancer","volume":"16","author":"Golara","year":"2024","journal-title":"Cancers (Basel) [Internet]."},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2022.09.004","article-title":"Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer","volume":"167","author":"Hou","year":"2022","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0435","article-title":"Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer","volume":"19","author":"Feng","year":"2021","journal-title":"J. Transl. Med. [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0440","article-title":"Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study","volume":"13","author":"Nair","year":"2016","journal-title":"PLOS Med. [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0445","article-title":"Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer","volume":"16","author":"Grassi","year":"2021","journal-title":"PLoS One [Internet]"},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0450","article-title":"Sensitive circulating tumor DNA\u2013based residual disease detection in epithelial ovarian cancer","volume":"7","author":"Kallio","year":"2024","journal-title":"Life Sci. Alliance [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2023.12.025","article-title":"Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies","volume":"182","author":"Recio","year":"2024","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0460","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1158\/2159-8290.CD-18-0715","article-title":"BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma","volume":"9","author":"Lin","year":"2019","journal-title":"Cancer Discov. [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0465","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1200\/JCO.2016.70.4627","article-title":"Reversion of BRCA1\/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer","volume":"35","author":"Christie","year":"2017","journal-title":"J. Clin. Oncol. [Internet]."},{"issue":"10","key":"10.1016\/j.cca.2026.122873_bb0470","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/ijc.34435","article-title":"Noninvasive detection of microsatellite instability in patients with endometrial cancer","volume":"152","author":"Casas-Arozamena","year":"2023","journal-title":"Int. J. Cancer [Internet]"},{"issue":"23","key":"10.1016\/j.cca.2026.122873_bb0475","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-19-1324","article-title":"Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel","volume":"25","author":"Willis","year":"2019","journal-title":"Clin. Cancer Res. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0480","article-title":"Tumor Mutational Burden in Cervical Cancer as Potential Marker for Immunotherapy Responders","volume":"17(18):2963","author":"Kowalkowska","year":"2025","journal-title":"Cancers (Basel) [Internet]."},{"issue":"15","key":"10.1016\/j.cca.2026.122873_bb0485","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.3390\/cancers14153697","article-title":"Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer","volume":"14","author":"Paracchini","year":"2022","journal-title":"Cancers (Basel) [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0490","article-title":"Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis","volume":"8","author":"Cui","year":"2015","journal-title":"J. Ovarian Res. [Internet]."},{"issue":"6","key":"10.1016\/j.cca.2026.122873_bb0495","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/cancers14061405","article-title":"Liquid Biopsy for Monitoring EC Patients: Towards Personalized Treatment","volume":"14","author":"Pi\u00f1eiro-P\u00e9rez","year":"2022","journal-title":"Cancers (Basel) [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0500","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2015.08.001","article-title":"Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation","volume":"27","author":"Sood","year":"2015","journal-title":"Clin. Oncol. [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0505","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2016.07.093","article-title":"A microRNA expression signature for clinical response in locally advanced cervical cancer","volume":"142","author":"Pedroza-Torres","year":"2016","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"433","key":"10.1016\/j.cca.2026.122873_bb0510","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2024.12.004","article-title":"Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial","volume":"192","author":"Aza\u00efs","year":"2025","journal-title":"Gynecol. Oncol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2025.12.008","article-title":"Prognostic value of perioperative circulating tumor DNA in endometrial cancer: systematic review & meta-analysis","volume":"205","author":"Ahmed","year":"2026","journal-title":"Gynecol. Oncol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0525","first-page":"15","article-title":"Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis","author":"Zhao","year":"2025","journal-title":"Front. Oncol. [Internet]."},{"issue":"9","key":"10.1016\/j.cca.2026.122873_bb0530","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.annonc.2025.05.533","article-title":"Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses","volume":"36","author":"Mayadev","year":"2025","journal-title":"Ann. Oncol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0535","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2024.11.002","article-title":"The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer","volume":"192","author":"Shu","year":"2025","journal-title":"Gynecol. Oncol. [Internet]."},{"issue":"4","key":"10.1016\/j.cca.2026.122873_bb0540","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.23.00954","article-title":"Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer","volume":"42","author":"Han","year":"2024","journal-title":"J. Clin. Oncol. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0545","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.107755","article-title":"Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis","volume":"300","author":"Wang","year":"2024","journal-title":"Eur. J. Obstet & Gynecol. Reprod Biol. [Internet]"},{"key":"10.1016\/j.cca.2026.122873_bb0550","first-page":"1","article-title":"Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma","volume":"2022","author":"Wu","year":"2022","journal-title":"J. Oncol. [Internet]."},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0555","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/ijms27031305","article-title":"Concordance of Genomic Alterations in Ovarian Cancer Tissues and Circulating-Tumor DNA: A Pilot Study","volume":"27","author":"Kang","year":"2026","journal-title":"Int. J. Mol. Sci. [Internet]."},{"issue":"15_suppl","key":"10.1016\/j.cca.2026.122873_bb0560","doi-asserted-by":"crossref","first-page":"e21103","DOI":"10.1200\/JCO.2021.39.15_suppl.e21103","article-title":"Liquid biopsies for the front line therapy decision in non-small cell lung cancer","volume":"39","author":"Brice","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.122873_bb0565","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cllc.2022.11.007","article-title":"Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)","volume":"24","author":"Raez","year":"2023","journal-title":"Clin. Lung. Cancer [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0570","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40291-019-00442-w","article-title":"Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions","volume":"24","author":"Sorber","year":"2019","journal-title":"Mol. Diagnosis & Ther. [Internet]"},{"issue":"7","key":"10.1016\/j.cca.2026.122873_bb0575","article-title":"Cost-effectiveness assessment of liquid biopsy for early detection of lung cancer in Brazil","volume":"20","author":"Senna","year":"2025","journal-title":"PLoS One [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0580","article-title":"Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients","volume":"8","author":"Vasseur","year":"2024","journal-title":"npj Precis Oncol. [Internet]."},{"issue":"403","key":"10.1016\/j.cca.2026.122873_bb0585","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci. Transl. Med. [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0590","series-title":"NCI Biospecimen Evidence-Based Practices (BEBP) - Cell-free DNA: Biospecimen Collection and Processing v1 [Internet]","author":"Biorepositories and Biospecimen Research Branch NCI","year":"2024"},{"issue":"3","key":"10.1016\/j.cca.2026.122873_bb0595","article-title":"Socioeconomic impact of artificial intelligence\u2013driven point-of-care testing devices for liquid biopsy in the OncoCheck system","volume":"44","author":"Singh","year":"2025","journal-title":"Cancer Metastasis Rev. [Internet]."},{"issue":"11","key":"10.1016\/j.cca.2026.122873_bb0600","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1039\/C6LC90046A","article-title":"Smart biosensors for multiplexed and fully integrated point-of-care diagnostics","volume":"16","author":"Romeo","year":"2016","journal-title":"Lab Chip [Internet]."},{"key":"10.1016\/j.cca.2026.122873_bb0605","first-page":"100651","article-title":"Digital sensing technologies in cancer care: A new era in early detection and personalized diagnosis","volume":"26","author":"Yucel","year":"2025","journal-title":"Biosens. Bioelectron. X [Internet]."},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0610","article-title":"Single-cell low-pass whole genome sequencing accurately detects circulating tumor cells for liquid biopsy-based multi-cancer diagnosis","volume":"8","author":"Shen","year":"2024","journal-title":"npj Precis Oncol. [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0615","article-title":"An artificial intelligence-based model for prediction of clonal hematopoiesis variants in cell-free DNA samples","volume":"9","author":"Arango-Argoty","year":"2025","journal-title":"npj Precis Oncol. [Internet]"},{"issue":"1","key":"10.1016\/j.cca.2026.122873_bb0620","article-title":"A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection","volume":"9","author":"Shen","year":"2025","journal-title":"npj Precis Oncol. [Internet]"},{"issue":"10409","key":"10.1016\/j.cca.2026.122873_bb0625","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet [Internet]."},{"issue":"12","key":"10.1016\/j.cca.2026.122873_bb0630","article-title":"Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS One [Internet]"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:52:09Z","timestamp":1791687129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126020553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":126,"alternative-id":["S0009898126020553"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122873","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy for early detection and biomarker applications in gynecological cancers: current status and future directions","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122873"}}